IRCT20200105046010N11尚未招募未知
In-vivo Bioequivalence Test of Rosuvastatin tablets in comparison with brand name drug (CRESTOR® 20mg F.C Tab.) Made by ASTRA-Zeneca, UK.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test of Rosuvastatin tablets with brand drug (CRESTOR® 20mg F.C Tab, AstraZeneca, Belgium)IRCT20200105046010N41Kharazmi Pharmaceutical Co24
已完成
不适用
Bioequivalence study of Rosuvastatin 40 mg tablet in 24 healthy male under fasting conditionsIRCT20180620040164N25Karen Pharma and Food Supplement Co.24
招募中
不适用
Bioequivalence study of Rosuvastatin 40 mg tablet in 24 healthy male under fasting conditionsIRCT20180620040164N22Dorsa Pharmaceutical Co.24
尚未招募
不适用
Bioequivalence Study of Rosuvastatin 40 mg in Healthy Thai Volunteers under Fasting ConditionsBioequivalence of generic rosuvastatinTCTR20170322003All Research Co., Ltd.42
已完成
不适用
Bioequivalence Study of Rosuvastatin 20 mg in Healthy Thai Volunteers under Fasting ConditionsBioequivalence of generic rosuvastatinTCTR20170315001All Research Co., Ltd.42